Stable laquinimod preparations
US8383645B2 · kind B2 · utility
9Cited by
22References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2012 |
| Grant date | Feb 26, 2013 |
| Priority date | — |
| Expiry date | Aug 7, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt of N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, N-methylglucamine, and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.